Company Overview

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

  • Name

    Altria Group, Inc.

  • CEO

    William F. Gifford Jr.

  • Website

    www.altria.com

  • Sector

    Tobacco

  • Year Founded

    1822

Company Statistics

Profile

  • Market Cap

  • EV

  • Shares Out

  • Revenue

  • Employees

Margins

  • Gross

  • EBITDA

  • Operating

  • Pre-Tax

  • Net

  • FCF

Returns (5Yr Avg)

  • ROA

  • ROTA

  • ROE

  • ROCE

  • ROIC

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

  • Net Debt

  • Debt/Equity

  • EBIT/Interest

Growth (CAGR)

  • Rev 3Yr

  • Rev 5Yr

  • Rev 10Yr

  • Dil EPS 3Yr

  • Dil EPS 5Yr

  • Dil EPS 10Yr

  • Rev Fwd 2Yr

  • EBITDA Fwd 2Yr

  • EPS Fwd 2Yr

  • EPS LT Growth Est

Dividends

  • Yield

  • Payout

  • DPS

  • DPS Growth 3Yr

  • DPS Growth 5Yr

  • DPS Growth 10Yr

  • DPS Growth Fwd 2Yr

Bulls Say

  • The US market, while mature in volume terms, is a highly affordable one relative to other developed markets. This leaves headroom for price increases for many years.

  • Altria’s dominant market share in US cigarettes and oral tobacco has created a distribution system that few competitors can match for launching next-generation production.

  • The business generates massive free cash flow margins that allow for significant return of capital to shareholders as well as insulating the potential damage from M&A missteps.

Bears Say

  • As a US pure play, Altria lacks exposure to some of the emerging markets in which total tobacco consumption is increasing, leaving it subject to the 5% annual rate of domestic secular decline that we estimate.

  • The FDA appears to have taken a more aggressive approach to cigarette regulation in recent years. It is examining a ban of the use of menthol and a lowering of nicotine in cigarettes.

  • With cigarette volume in secular decline, multiple nicotine alternatives are emerging, limiting the scale and profitability potential of each emerging category.

Source: Morningstar Analysis - Nov 07, 2025

What's happening

Nov 5, 2025 - Dec 5, 2025

Altria Group Inc: Navigating Market Challenges Amidst Dividend Appeal

  • Altria's stock demonstrated a total price movement of 1.9% over the past month, outperforming the S&P 500's return of 1.3%.
  • Positive sentiment surrounding Altria was fueled by discussions on social media highlighting its attractive dividend yield and transformation within the tobacco industry.
  • Despite some bullish trends, concerns about competition from emerging products and regulatory scrutiny created headwinds for investor confidence.

Over the past month, Altria Group Inc (MO) experienced a total price movement of 1.9%, indicating modest resilience in its stock amidst fluctuating market conditions. The sentiment surrounding MO leaned predominantly bullish, particularly highlighted by social media discussions that emphasized its appealing dividend yield and ongoing transformation within the tobacco sector. On November 25th, significant enthusiasm emerged as posts praised MO for its quality dividends and suggested it was an attractive option for income-focused investors.

However, not all news favored MO during this period; bearish sentiments were also present throughout November. On December 2nd, despite reaching a four-week high at $59.33 earlier in the month, concerns arose regarding competition from emerging products like IQOS and HILO that could negatively impact Altria's market position. Additionally, legal challenges surfaced when California Attorney General Bonta urged Shopify to address illegal e-cigarette sales linked to brands competing with Altria’s offerings.

The competitive landscape remained a focal point as users noted that while MO had lagged behind tech stocks historically since prior bull runs began in 2021, it still showed relative strength against some peers within its sector despite recent fluctuations across various industries' stock prices. Furthermore, mentions of "The Great Re-Nicotinization" reflected sustained consumer interest across demographics for nicotine products—an encouraging sign amid evolving market dynamics.

Overall, while Altria Group Inc demonstrated solid performance relative to broader indices over this one-month period due to its dividend appeal and strategic positioning within an evolving industry landscape, it faced notable headwinds from competition and regulatory scrutiny impacting investor sentiment negatively at times during this timeframe. Notably though is that Altria Group Inc underperformed the Consumer Staples (XLP) sector by -1.3%.

NYSE:MO